Last updated: 11 September 2024 at 4:15pm EST

Richard Scalzo Net Worth




The estimated Net Worth of Richard William Scalzo is at least $10.8 Million dollars as of 11 September 2024. Mr Scalzo owns over 1,468 units of Dyne Therapeutics stock worth over $3,258,631 and over the last 4 years he sold DYN stock worth over $7,565,972.

Mr Scalzo DYN stock SEC Form 4 insiders trading

Mr has made over 20 trades of the Dyne Therapeutics stock since 2021, according to the Form 4 filled with the SEC. Most recently he sold 1,468 units of DYN stock worth $46,815 on 11 September 2024.

The largest trade he's ever made was selling 126,074 units of Dyne Therapeutics stock on 6 September 2024 worth over $4,053,279. On average, Mr trades about 11,747 units every 39 days since 2020. As of 11 September 2024 he still owns at least 99,958 units of Dyne Therapeutics stock.

You can see the complete history of Mr Scalzo stock trades at the bottom of the page.





Mr. Richard Scalzo biography

Richard Scalzo is the VP of Accounting & Admin. and Treasurer at Dyne Therapeutics.



How old is Mr Scalzo?

Mr Scalzo is 33, he's been the VP of Accounting & Admin. and Treasurer of Dyne Therapeutics since . There are 25 older and no younger executives at Dyne Therapeutics. The oldest executive at Dyne Therapeutics, Inc. is Yuezhou Ou, 68, who is the Independent Non-Executive Director.

What's Mr Scalzo's mailing address?

Richard's mailing address filed with the SEC is C/O DYNE THERAPEUTICS, INC., 1560 TRAPELO ROAD, WALTHAM, MA, 02451.

Insiders trading at Dyne Therapeutics

Over the last 4 years, insiders at Dyne Therapeutics have traded over $197,573,300 worth of Dyne Therapeutics stock and bought 5,790,447 units worth $92,382,301 . The most active insiders traders include Capital Management, L.P.Kol..., Jason P Rhodes und Dirk Kersten. On average, Dyne Therapeutics executives and independent directors trade stock every 12 days with the average trade being worth of $3,566,016. The most recent stock trade was executed by Oxana Beskrovnaya on 11 September 2024, trading 2,161 units of DYN stock currently worth $68,914.



What does Dyne Therapeutics do?

Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. The company was incorporated in 2017 and is headquartered in Waltham, Massachusetts..



What does Dyne Therapeutics's logo look like?

Dyne Therapeutics, Inc. logo

Complete history of Mr Scalzo stock trades at Dyne Therapeutics

Datum
#
Unternehmen
Insider
Trans.
Transaktion
Anzahl der Aktien Preis je Aktie Gesamtpreis Anzahl der Aktien nach Quelle
11 Sep 2024 Richard William Scalzo
SVP, Head of Finance und Admin.
Verkauf 1,468 $31.89 $46,815
11 Sep 2024
99,958
6 Sep 2024 Richard William Scalzo
SVP, Head of Finance und Admin.
Verkauf 126,074 $32.15 $4,053,279
6 Sep 2024
101,426
19 Aug 2024 Richard William Scalzo
SVP, Head of Finance und Admin.
Verkauf 2,752 $45.12 $124,170
19 Aug 2024
111,022
10 Jun 2024 Richard William Scalzo
SVP, Head of Finance und Admin.
Verkauf 2,921 $30.74 $89,792
10 Jun 2024
113,774
16 May 2024 Richard William Scalzo
SVP, Head of Finance und Admin.
Verkauf 2,588 $28.27 $73,163
16 May 2024
116,695
8 Mar 2024 Richard William Scalzo
SVP, Head of Finance und Admin.
Verkauf 88,924 $26.19 $2,328,920
8 Mar 2024
119,283
7 Mar 2024 Richard William Scalzo
SVP, Head of Finance und Admin.
Verkauf 2,273 $25.85 $58,757
7 Mar 2024
121,955
29 Feb 2024 Richard William Scalzo
SVP, Head of Finance und Admin.
Optionausübung 12,740 $1.03 $13,122
29 Feb 2024
133,539
26 Jan 2024 Richard William Scalzo
SVP, Head of Finance und Admin.
Optionausübung 13,000 $1.03 $13,390
26 Jan 2024
137,228
3 Jan 2024 Richard William Scalzo
SVP, Head of Finance und Admin.
Optionausübung 13,000 $1.03 $13,390
3 Jan 2024
137,228
14 Dec 2023 Richard William Scalzo
SVP, Head of Finance und Admin.
Verkauf 2,376 $12.02 $28,560
14 Dec 2023
124,228
11 Dec 2023 Richard William Scalzo
SVP, Head of Finance und Admin.
Verkauf 1,380 $10.72 $14,794
11 Dec 2023
126,604
4 Dec 2023 Richard William Scalzo
SVP, Head of Finance und Admin.
Verkauf 2,553 $12.01 $30,662
4 Dec 2023
127,984
18 Sep 2023 Richard William Scalzo
SVP, Head of Finance und Admin.
Verkauf 1,290 $9.41 $12,139
18 Sep 2023
40,795
12 Sep 2023 Richard William Scalzo
SVP, Head of Finance und Admin.
Verkauf 1,397 $10.41 $14,543
12 Sep 2023
42,085
13 Jun 2023 Richard William Scalzo
SVP, Head of Finance und Admin.
Verkauf 51,390 $12.71 $653,167
13 Jun 2023
43,482
14 Mar 2023 Richard William Scalzo
SVP, Head of Finance und Admin.
Verkauf 1,311 $13.33 $17,476
14 Mar 2023
54,872
9 Dec 2022 Richard William Scalzo
SVP, Head of Finance und Admin.
Verkauf 312 $10.87 $3,391
9 Dec 2022
56,183
11 Mar 2022 Richard William Scalzo
SVP, Head of Finance und Admin.
Verkauf 308 $8.73 $2,689
11 Mar 2022
26,994
20 Sep 2021 Richard William Scalzo
SVP, Head of Finance und Admin.
Verkauf 859 $15.90 $13,658
20 Sep 2021
10,606


Dyne Therapeutics executives and stock owners

Dyne Therapeutics executives and other stock owners filed with the SEC include: